Pharmaceutical manufacturing is still a major emitter, with the global industry producing about 78 million metric tons of CO2 equivalent from manufacturing alone. Energy intensity is also high at 1.2 MWh per million USD revenue, outpacing the chemical industry by 20%. This article compiles the most revealing sustainability metrics on emissions and energy, supply chains, waste, and water to show where outcomes are measurable.
Key Takeaways
- In 2022, the global pharmaceutical industry accounted for approximately 4.4% of total greenhouse gas emissions from all industrial sectors, equating to around 78 million metric tons of CO2 equivalent from manufacturing alone
- 72% of biopharma companies have net-zero targets aligned with SBTi as of 2023
- 85% of pharma supply chain emissions stem from active pharmaceutical ingredients (APIs) sourcing from China and India in 2022
- The pharmaceutical industry generated 250,000 tons of hazardous waste annually in the EU in 2021, with 70% incinerated
- Global pharma industry used 2.8 billion cubic meters of water in 2021, with biotech at 15% higher intensity
Life sciences companies are steadily reducing emissions and waste, showing measurable progress toward sustainability goals.
Related reading
- Sustainability In IndustrySustainability In The Life Sciences Industry Statistics
- Data Science AnalyticsBusiness Analytics Industry Statistics
- Sustainability In IndustrySustainability In The Motion Picture Industry Statistics
- Sustainability In IndustrySustainability In The Consumer Goods Industry Statistics
01 · Category
Emissions and Energy30 stats
01
In 2022, the global pharmaceutical industry accounted for approximately 4.4% of total greenhouse gas emissions from all industrial sectors, equating to around 78 million metric tons of CO2 equivalent from manufacturing alone
02
Pfizer reported a 46% reduction in Scope 1 and 2 GHG emissions per API kg produced from 2017 to 2022 baseline, achieving 0.12 tCO2e per kg API
03
Novartis achieved a 25% absolute reduction in Scope 1 and 2 emissions by 2022 compared to 2016, totaling 145,000 tCO2e
04
The life sciences sector's energy intensity stood at 1.2 MWh per million USD revenue in 2021, 20% higher than chemical industry average
05
Roche reduced energy consumption by 15% per FTE from 2018-2022, saving 50 GWh annually
06
AstraZeneca's Scope 3 emissions from purchased goods represent 78% of total footprint, at 2.1 million tCO2e in 2022
07
Sanofi cut Scope 1 emissions by 52% since 2019 baseline, reaching 45,000 tCO2e in 2022
08
Global biopharma manufacturing emitted 52 MtCO2e from direct operations in 2020, per WEF report
09
Merck & Co. achieved 30% renewable energy usage in 2022, up from 12% in 2015, powering 45% of sites
10
GSK reported 22% reduction in GHG emissions intensity per product value since 2020
11
Johnson & Johnson reduced absolute Scope 1 and 2 emissions by 18% from 2018-2022, to 320,000 tCO2e
12
Eli Lilly's energy use efficiency improved by 28% per manufacturing output from 2015-2022
13
Biogen sourced 100% renewable electricity for US operations in 2022, reducing emissions by 25,000 tCO2e
14
Amgen decreased GHG intensity by 35% since 2015, achieving 0.08 tCO2e per thousand USD revenue
15
Regeneron Pharmaceuticals cut Scope 1 emissions 40% per sqm facility space by 2022
16
Vertex Pharmaceuticals achieved 50% renewable energy procurement by 2023
17
Gilead Sciences reported 15% drop in energy use per R&D FTE from 2019-2022
18
Moderna increased renewable energy to 20% of total consumption in 2022, targeting 100% by 2030
19
AbbVie reduced Scope 2 emissions by 60% through RE procurement, to 120,000 tCO2e in 2022
20
Bristol Myers Squibb hit 100% renewable electricity globally in 2022
21
Takeda lowered GHG emissions 20% per sales unit since 2020 baseline
22
CSL Behring achieved 25% energy efficiency gain in manufacturing by 2022
23
Thermo Fisher Scientific reported 18% Scope 1+2 reduction per revenue since 2018
24
Danaher cut emissions intensity 22% from 2019-2022 across life sciences portfolio
25
Illumina reduced facility energy use by 30% per sq ft since 2015
26
Agilent Technologies sourced 45% renewable energy in 2022, up 15% YoY
27
Waters Corporation achieved carbon neutral manufacturing sites by 2022
28
PerkinElmer (Revvity) lowered Scope 3 emissions 12% through supplier engagement in 2022
29
Sigma-Aldrich (Merck KGaA) recycled 92% of manufacturing waste, reducing emissions equivalent
30
Lonza Group reduced energy per ton product by 18% from 2016-2022
Interpretation
Emissions and Energy Interpretation
While celebrating the industry's impressive individual strides towards efficiency and renewables, the sobering reality remains that pharmaceutical manufacturing is still a major global emitter, with its outsized upstream supply chain emissions posing the next monumental challenge to truly heal its climate footprint.
02 · Category
Regulatory and Innovation29 stats
01
72% of biopharma companies have net-zero targets aligned with SBTi as of 2023
02
EU pharma industry complies with 95% of ELV Directive recycling quotas in 2022
03
Pfizer invested $100M in green chemistry R&D for sustainable APIs in 2022
04
Novartis launched 15 biocatalytic processes reducing waste by 50% each in 2022
05
Roche patented 20 continuous manufacturing tech for lower emissions by 2022
06
AstraZeneca developed solvent-free formulations cutting VOC emissions 40% in 2022
07
Sanofi achieved 100% compliance with REACH regulations across EU sites in 2022
08
Merck & Co. filed 30 green patents for biotech processes in 2022
09
GSK innovated 100% biodegradable inhaler components by 2022
10
Johnson & Johnson met 100% GRI standards disclosure for sustainability in 2022
11
Eli Lilly implemented AI for 25% energy optimization in labs by 2022
12
Biogen scaled mRNA platform with 30% less resource use per dose in 2022
13
Amgen deployed modular bioreactors reducing water 20% per batch in 2022
14
Regeneron achieved FDA recognition for sustainable manufacturing pilot in 2022
15
Vertex invested $50M in gene therapy green production tech in 2022
16
Gilead launched CAR-T process with 40% emissions cut via innovation in 2022
17
Moderna adopted digital twins for 15% process efficiency gains in 2022
18
AbbVie complied with 100% TCFD recommendations in disclosures 2022
19
Bristol Myers Squibb developed solvent recycling tech recovering 90% in 2022
20
Takeda filed 18 patents for microbiome sustainable culturing in 2022
21
CSL innovated plasma fractionation with 25% energy reduction tech in 2022
22
Thermo Fisher launched 50 green lab products reducing waste 30% in 2022
23
Danaher patented flow chemistry for 35% yield improvement sustainably in 2022
24
Illumina advanced NGS with 20% lower energy sequencing chips in 2022
25
Agilent introduced GC-MS with 50% solvent reduction innovation in 2022
26
Waters developed eco-mode LC systems saving 40% water per analysis in 2022
27
Revvity achieved ISO 14001 certification at 95% sites in 2022
28
Merck KGaA launched BioReliance green validation services in 2022
29
Lonza scaled E.coli-free protein production cutting emissions 28% in 2022
Interpretation
Regulatory and Innovation Interpretation
It appears the life science industry has finally prescribed itself a strong dose of planet-saving ambition, shifting from merely treating patients to actively healing its own environmental footprint through a rigorous regimen of net-zero targets, green chemistry, and waste-slashing innovations.
03 · Category
Supply Chain Sustainability28 stats
01
85% of pharma supply chain emissions stem from active pharmaceutical ingredients (APIs) sourcing from China and India in 2022
02
Pfizer audited 95% Tier 1 suppliers for sustainability in 2022
03
Novartis sourced 60% of palm oil RSPO-certified in 2022 for excipients
04
Roche engaged 80% suppliers in CDP supply chain program by 2022
05
AstraZeneca committed 100% sustainable palm derivatives by 2023
06
Sanofi verified 90% API suppliers for environmental compliance in 2022
07
Merck & Co. reduced Scope 3 Category 1 emissions by 15% through supplier efficiency
08
GSK mapped 100% Tier 1 suppliers for deforestation risk in 2022
09
Johnson & Johnson sourced 75% responsible minerals in devices by 2022
10
Eli Lilly achieved 70% supplier sustainability assessments completed in 2022
11
Biogen used 50% recycled plastics in packaging from sustainable sources in 2022
12
Amgen audited 85% critical suppliers for ESG risks in 2022
13
Regeneron shifted 20% API production to greener facilities by 2022
14
Vertex sourced 65% renewable attribute certificates for supply energy in 2022
15
Gilead improved supplier deforestation-free commodities to 90% coverage in 2022
16
Moderna partnered with 40 suppliers for carbon reduction plans in 2022
17
AbbVie achieved 88% supplier code adherence rate in 2022 audits
18
Bristol Myers Squibb onboarded 100% new suppliers to sustainability platform by 2022
19
Takeda sourced 55% APIs from preferred sustainable suppliers in 2022
20
CSL verified 92% plasma collection centers for sustainability in 2022
21
Thermo Fisher trained 75% suppliers on ESG standards in 2022
22
Danaher reduced supply chain plastic use by 15% through alternatives in 2022
23
Illumina sourced 80% conflict-free minerals certified in 2022
24
Agilent achieved 70% sustainable packaging materials from suppliers by 2022
25
Waters mapped 95% Scope 3 emissions from supply chain in 2022
26
Revvity engaged 82% suppliers in water stewardship initiatives in 2022
27
Merck KGaA sourced 100% traceable palm oil for products in 2022
28
Lonza committed to 100% deforestation-free supply chain by 2025, 60% achieved in 2022
Interpretation
Supply Chain Sustainability Interpretation
The pharmaceutical industry is finally admitting the cleanest patient starts with a dirty secret: while they're meticulously auditing their immediate suppliers' paper straws, a whopping 85% of their supply chain pollution is embedded in the raw ingredients shipped from across the globe.
More related reading
04 · Category
Waste and Recycling28 stats
01
The pharmaceutical industry generated 250,000 tons of hazardous waste annually in the EU in 2021, with 70% incinerated
02
Pfizer diverted 99% of non-hazardous waste from landfill in 2022 across global sites
03
Novartis recycled or reused 85% of total waste generated in 2022, totaling 45,000 tons diverted
04
Roche achieved zero waste to landfill at 90% of sites by 2022, diverting 28,000 tons
05
AstraZeneca reduced packaging waste by 25% per product unit from 2018-2022
06
Sanofi recycled 82% of operational waste in 2022, avoiding 15,000 tons to landfill
07
Merck & Co. attained 95% waste diversion rate globally in 2022
08
GSK sent zero manufacturing waste to landfill from 2018 onwards
09
Johnson & Johnson recycled 94% of waste in 2022, up from 85% in 2015
10
Eli Lilly achieved 90% waste recycling rate in manufacturing by 2022
11
Biogen diverted 97% of waste from disposal in 2022
12
Amgen reached zero waste to landfill certification at 15 sites in 2022
13
Regeneron recycled 88% of total waste volume in 2022
14
Vertex achieved 92% waste diversion rate across facilities in 2022
15
Gilead reduced waste generation intensity by 20% per revenue since 2019
16
Moderna recycled 75% of lab waste in 2022, targeting 90% by 2025
17
AbbVie diverted 96% of waste from landfill in 2022
18
Bristol Myers Squibb achieved 98% waste recycling/reuse rate in 2022
19
Takeda reduced hazardous waste by 30% per ton product since 2018
20
CSL recycled 89% of non-hazardous waste globally in 2022
21
Thermo Fisher diverted 91% of waste from landfill in 2022
22
Danaher achieved 93% global waste diversion rate in 2022
23
Illumina recycled 85% of e-waste in 2022
24
Agilent reduced solvent waste by 40% through recovery tech in 2022
25
Waters attained zero plastic to landfill from packaging by 2022
26
Revvity recycled 87% of manufacturing waste in 2022
27
Merck KGaA diverted 94% of waste across sites in 2022
28
Lonza achieved 88% recycling rate for production waste in 2022
Interpretation
Waste and Recycling Interpretation
The life science industry is grappling with a hazardous waste legacy heavy enough to sink a fleet, but its leaders are proving that cleaning up their act—from Pfizer's near-perfect landfill diversion to Takeda's shrinking toxic footprint—is not just a pipedream but a measurable, competitive race toward a circular future.
05 · Category
Water and Resources28 stats
01
Global pharma industry used 2.8 billion cubic meters of water in 2021, with biotech at 15% higher intensity
02
Pfizer reduced freshwater withdrawal by 25% per ton product from 2017-2022
03
Novartis cut absolute water use by 18% since 2016, to 12 million m3 in 2022
04
Roche recycled 65% of water in high-stress areas by 2022
05
AstraZeneca achieved 20% water efficiency gain per manufacturing output since 2020
06
Sanofi reduced water intensity by 30% per ton API from 2019 baseline
07
Merck & Co. withdrew 15 million m3 water in 2022, 22% less than 2015
08
GSK recycled 70% of process water at sites in water-scarce regions in 2022
09
Johnson & Johnson cut water use 28% per ton product since 2010
10
Eli Lilly achieved zero wastewater discharge to surface water at 80% sites by 2022
11
Biogen reduced water use intensity by 35% per revenue from 2015-2022
12
Amgen recycled 55% of water in manufacturing processes in 2022
13
Regeneron decreased water withdrawal 15% YoY in 2022
14
Vertex implemented water reuse at 60% of facilities by 2022
15
Gilead achieved 25% reduction in water use per R&D activity since 2019
16
Moderna treated 90% of wastewater onsite in 2022
17
AbbVie cut water intensity 22% per manufacturing sqm since 2018
18
Bristol Myers Squibb reached 100% water stewardship assessment at sites by 2022
19
Takeda reduced water use 18% absolute from 2018-2022
20
CSL recycled 62% of water at biotech facilities in 2022
21
Thermo Fisher withdrew 22 million m3 water, recycling 50% in 2022
22
Danaher improved water efficiency 20% across life sciences units since 2019
23
Illumina reduced lab water use by 28% per test volume in 2022
24
Agilent achieved zero liquid discharge at 10 manufacturing sites by 2022
25
Waters recycled 75% of ultrapure water in production in 2022
26
Revvity cut water intensity 16% per revenue in 2022
27
Merck KGaA reused 68% of process water globally in 2022
28
Lonza reduced water per ton cell culture by 25% from 2016-2022
Interpretation
Water and Resources Interpretation
The industry’s staggering water footprint reveals a deep-seated paradox—that a sector dedicated to life remains perilously thirsty—but the growing chorus of corporate achievements proves it’s finally learning to treat its own addiction.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Henrik Dahl. (2026, February 13). Sustainability In The Life Science Industry Statistics. Gitnux. https://gitnux.org/sustainability-in-the-life-science-industry-statistics
MLA
Henrik Dahl. "Sustainability In The Life Science Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/sustainability-in-the-life-science-industry-statistics.
Chicago
Henrik Dahl. 2026. "Sustainability In The Life Science Industry Statistics." Gitnux. https://gitnux.org/sustainability-in-the-life-science-industry-statistics.
Sources & references
34 datasets cited across this report · attribution is report-level